Our findings suggest that conventional MR imaging-based radiomic features combined with machine/deep learning methods may be valuable in discriminating IDH-mutant grade 4 astrocytomas from IDH-wild-type GBMs. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).